BETHESDA, Md., March 25, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (“Gain”) today announced the closing of its initial public offering of 3,636,364 shares of …
BETHESDA, Md., March 18, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (“Gain”) today announced the pricing of its initial public offering of 3,636,364 shares of …
10 Mar: Gain Therapeutics Files Registration Statement with SEC for Proposed Initial Public Offering
BETHESDA, Md., March 10, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (“Gain”) today announced that it has launched the roadshow for its initial public offering …
STAR candidates for the treatment of Gaucher Disease enhance GCase activity in a neuronal cell model and reduce toxic accumulation of GCase substrate STAR candidates …
BETHESDA, Md., Feb. 04, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc., (“Gain”) a biotechnology company focused on redefining drug discovery by identifying and optimizing allosteric …
BETHESDA, Md., Feb. 02, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (“Gain”) today announced the addition of Dov Goldstein, M.D., Gwen Melincoff, Claude Nicaise, M.D. …
– Researchers will further develop the Site-directed Enzyme Enhancement Therapy (SEE-Tx)™ technology for the treatment of rare genetic and neurodegenerative diseases – The collaborative agreement …
Partnership to investigate Gain’s structurally targeted allosteric regulator candidates (STARs) in cellular models of Gaucher disease and Parkinson’s disease November 30, 2020 09:40 ET | …
October 13, 2020 08:00 ET | Source: Gain Therapeutics BETHESDA, Md., Oct. 13, 2020 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc., (“Gain”) a biotechnology company focused …
Collaboration to Focus on Rare Genetic and Demyelinating Diseases, Including Lysosomal Storage Diseases September 10, 2020 08:00 ET | Source: Gain Therapeutics BETHESDA, Md., Sept. …
September 12, 2019 02:30 AM Eastern Daylight Time LUGANO, Switzerland–(BUSINESS WIRE)–Gain Therapeutics SA, a biotechnology company discovering and developing novel therapeutics to target lysosomal enzymes …
July 21, 2020 08:00 ET | Source: Gain Therapeutics Financing intended to accelerate IND-enabling studies of allosteric drug candidates for rare genetic and neurodegenerative diseases, …
July 23, 2019 02:30 AM Eastern Daylight Time LUGANO, Switzerland & BELLINZONA, Switzerland & GARDANNE, France–(BUSINESS WIRE)–Gain Therapeutics SA, a biotechnology company discovering and developing …
February 26, 2019 02:30 AM Eastern Standard Time LUGANO, Switzerland & BARCELONA, Spain–(BUSINESS WIRE)–Gain Therapeutics SA (a biotechnology company discovering and developing novel therapeutics to …
February 19, 2019 02:30 AM Eastern Standard Time LUGANO, Switzerland–(BUSINESS WIRE)–GT Gain Therapeutics SA today announces that it has closed a €2.5 Million series A …